Biosensors market in 2025 is driven by advanced healthcare applications, dominated by oxidoreductase enzymes and non-wearable ...

The global wearable medical devices market size surpassed USD 42.71 billion in 2024 and is anticipated to reach around USD 430.76 billion by 2034, registering a CAGR of 26% from 2025 to 2034. A study ...

The wearable biosensor from Philadelphia’s Strados Labs started at a hackathon. It’s now helping determine if drugs are effective during clinical trials.

Wearable health technology enhances preventive care, enabling continuous monitoring of vital signs and proactive disease management for better health outcomes.

The global biosensors market is set for substantial growth, with a projected increase in market value from US$ 32.14 billion in 2024 to US$ 75.84 billion by 2033, reflecting a compound annual growth ...

Non-wearable biosensors are integrated into diagnostic devices, particularly those used in point-of-care testing, offering advantages such as ease of use, high accuracy, and immediate diagnostic ...

Biosensors are changing how we monitor health, but rapid innovation raises tough questions around privacy, regulation, and ...

From artificial intelligence (AI) to telemedicine and wearable health devices, innovations are redefining how care is ...

Yokneam Illit, Israel, March 24, 2025 (GLOBE NEWSWIRE) -- Wearable Devices Ltd. (the ... to Proactive Intelligence Unlike traditional bio-sensors that collect data passively, LMM continuously ...

Programmable electrodes integrated into wearable devices enable selective molecular detection in complex formulations such as ...